Wikipedia -WSS

Wikipedia

author：knowledge 2025-08-28 13:07:18 - browse：5

Illustration of a prescription bottle image on the screen of a smart phone – medical tech coverage from STAT — Alex Hogan/STAT

In another sign of the business headwinds facing prescription mental health apps, developer Twill will shop around for a pharmaceutical company to market Aspiro, its cognitive behavioral therapy treatment for both generalized anxiety and major depression.

Twill executives told STAT the company hopes that a drugmaker developing or currently marketing a product for generalized anxiety, or GAD, and major depressive disorder, or MDD, will be interested in adding a digital therapeutic to boost the effect of its drug — as well as its sales. Twill’s chief strategy officer Chris Wasden said that after watching companies built around prescription digital therapeutics, or PDTs, stall out, Twill made the decision earlier this year that it would only take the product to market if it found a willing drugmaker to serve as its partner.

“A PDT is going to be more valuable in the hands of a drug company that has a drug that they would like to get greater adherence [and] greater revenues from rather than trying to get reimbursement for the PDT itself,” he said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Dozens dead from Maui wildfires: What we know about the victims

Wikipedia

WSS

Dozens dead from Maui wildfires: What we know about the victims

Patients' immediate access to test results puts radiologists in a bind

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Illumina slashes 2023 revenue projections yet again

Patients, digital health players weigh in on FTC's data privacy plan

Supreme Court wrestles with OxyContin maker's bankruptcy deal

focus

Wikipedia

hotspot

Continuity nursing helped my family in our darkest PICU moments

The woman behind the Dana Farber

Medicare proposal to cover medical devices draws a mixed reaction

Health AI: on the border between health care and tech

How one medical school became remarkably diverse

Be careful with at

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Congenital heart disease patients face new threat of heart failure

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Roche to buy Carmot Therapeutics, developer of obesity drugs

focus

Montana youths win climate lawsuit against state for promoting fossil fuels

Surge in Apellis stock fueled by confidence in safety of its eye drug

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

BMS, looking to build heart drug business, turns to AI for diagnosis

Why sickle cell disease is getting the first CRISPR treatment

explore

knowledge

Wikipedia

focus